Home » Topics » Regulatory

Regulatory
RSS

FDA approves Orkambi for younger cystic fibrosis population

Sep. 29, 2016

FDA approves Rexulti labeling update for maintenance treatment of schizophrenia

Sep. 26, 2016

FDA approves adalimumab biosimilar Amjevita

Sep. 26, 2016

FDA grants accelerated approval to Exondys 51 for Duchenne muscular dystrophy

Sep. 20, 2016

FDA approves Aralez Pharmaceuticals' Yosprala

Sep. 16, 2016

Opdivo intravenous infusion approved in Japan for treatment of unresectable or metastatic RCC

Sep. 8, 2016

FDA approves Blincyto for pediatric patients with Ph-negative B-cell precursor ALL

Sep. 2, 2016

European Commission approves Pfizer's crizotinib for ROS-1 positive NSCLC

Sep. 1, 2016

FDA approves biosimilar etanercept Erelzi

Aug. 31, 2016

Hemispherx Biopharma's NDA for rintatolimod receives approval in Argentina

Aug. 24, 2016

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...